
Zoovu


Vesalius Biocapital is a European life sciences venture capital investor The active fund Vesalius Biocapital III had a final closing in May 2019 with € 120 million in commitments
We are investing in appealing, later-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, predominantly in Europe Our portfolio companies address unmet medical & market needs and operate on the basis of strong intellectual property protection
Vintage 2017 - € 120 million assets under management In investment mode
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Vesalius Biocapital III.
Similar listings buyers compare against this one.

Zoovu

AIM Group

Y Combinator

SOSV

Andreessen Horowitz (a16z)

Sentinel
Everything here links back to the same verified catalogue. Pick your next stop.